We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

StemCells, Inc.’s Phase I BATTEN Trial Data Featured at AANS Annual Meeting

News   May 05, 2010

 
StemCells, Inc.’s Phase I BATTEN Trial Data Featured at AANS Annual Meeting
 
 
 

RELATED ARTICLES

A Sobering Conclusion: Adult Hearts Do Not Contain Stem Cells

News

While cardiac stem cells (CSC) are of great interest for regenerative intervention, the significance of these populations remains heavily debated. A study published in PNAS did not find any evidence for the existence of a quiescent CSC population.

READ MORE

The Source of Stem Cells Points to Two Proteins

News

Negative feedback between HIPPO and Par complex components ensure robust lineage segregation in mice.

READ MORE

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE